浙江太美医疗科技股份有限公司（股票代码：02576）于2026年10月6日刊发公告，披露公司当日通过香港联交所场内回购普通股H股共15,200股，约占前一交易日已发行股本0.01%。本次回购价格区间为每股港币4.745元至4.89元，涉资总额约为港币7.32万元。
回购完成后，公司已发行股份(不包括库藏股)减至193,192,533股，库存股份增加至7,400,000股，合计200,592,533股。根据公告，股东大会已于2026年6月23日通过回购授权，本次回购前，公司已在交易所及其他证券交易所累计回购6,979,000股，约占授权通过当日已发行股本3.49%，尚可回购最多20,017,153股。
公告同时确认，公司已严格遵守香港联合交易所有限公司证券上市规则及相关法规。公告由执行董事及联席公司秘书倪晓梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.